Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Study: Firms 'Underinvest' in Long-Term Cancer Research

July 28, 2015 8:53 am | by MIT | News | Comments

Pharmaceutical firms under invest in long-term research to develop new cancer-fighting drugs due to the greater time and cost required to conduct such research. Read more...

TOPICS:

Innovative New Consortium Formed to Develop, Study Early Stage Drugs

July 28, 2015 8:46 am | by University of Cambridge | News | Comments

An innovative new Consortium will act as a match-making service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases. Read more...

TOPICS:

New Material Opens up Possibilities for Super-Long-Acting Pills

July 28, 2015 8:40 am | by MIT | News | Comments

Medical devices designed to reside in the stomach have a variety of applications, including prolonged drug delivery, electronic monitoring, and weight-loss intervention. Read more...

TOPICS:
Advertisement

Software Turns Smartphones into Tools for Medical Research

July 28, 2015 8:40 am | by Brandon Bailey, AP Technology Writer | News | Comments

Smartphone apps are the latest tools to emerge from the intersection of health care and Silicon Valley. Read more...

TOPICS:

Early Antiretroviral Therapy Prevents non-AIDS Outcomes in HIV Infected People

July 28, 2015 8:40 am | by National Institute of Health | News | Comments

NIH-supported findings illustrate manifold benefit of therapy. Read more...

TOPICS:

Sweet Revenge Against Superbugs

July 28, 2015 8:39 am | by University of Queensland | News | Comments

A special type of synthetic sugar could be the latest weapon in the fight against superbugs. Read more...

TOPICS:

Central Nervous System (CNS) Summit 2015

July 27, 2015 3:37 pm | Events

CNS Summit, a community dedicated to shaping the future of drug development.

Predicting Whether Children With a Genetic Disorder Will Develop Autism, Psychosis: Study

July 27, 2015 11:21 am | by University of California, Los Angeles | News | Comments

Doctors and researchers have long known that children who are missing about 60 genes on a certain chromosome are at a significantly elevated risk for developing either a disorder on the autism spectrum or psychosis—that is, any mental disorder characterized by delusions and hallucinations, including schizophrenia. Read more...

TOPICS:
Advertisement

AACC 2015: Research Expanded Upon for New Rapid Response Ebola Test

July 27, 2015 10:40 am | by Ryan Bushey, Associate Editor | Articles | Comments

The test is able to diagnose the virus in 15 minutes. Read more...

TOPICS:

Malaria's Key to the Liver Uncovered

July 27, 2015 10:18 am | News | Comments

Scientists uncover a port of liver entry for malaria parasites in a report published in The Journal of Experimental Medicine. If these results hold up in humans, drugs that target this entry protein might help prevent the spread of disease. Read more...

TOPICS:

Brain Disorder Center's Closing Sends Ripples Nationwide

July 27, 2015 10:09 am | by Kathleen Ronayne, AP | News | Comments

When Tyler Richardson's son hit puberty, the combination of hormones and new strength from a growth spurt added an element of danger to a long history of unpredictable behavior because of autism and severe anger problems. Read more...

TOPICS:

FDA OKs Breakthrough Cholesterol Drug for High-Risk Patients

July 27, 2015 10:03 am | by Matthew Perrone, AP Health Writer | News | Comments

The Food and Drug Administration on Friday approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades. Read more...

TOPICS:

Scientists Win $1.5 Million to Study New Strategies for Parkinson’s Disease and Other Disorders

July 27, 2015 9:54 am | by The Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded nearly $1.5 million from the National Institute of General Medical Sciences of the National Institutes of Health to explore the therapeutic potential of a class of proteins that play essential roles in the regulation and maintenance of human health. Read more...

TOPICS:

Bristol-Myers Wins Approval for 1st Hepatitis C Type 3 Drug

July 27, 2015 9:50 am | by Linda A. Johnson, AP Business Writer | News | Comments

An experimental drug for one of the hardest-to-treat types of hepatitis C has been approved by the Food and Drug Administration, adding to the surge of new options - all much more effective but extremely costly - for patients with the liver-destroying virus. Read more...

TOPICS:

Allergan to Acquire Naurex

July 27, 2015 8:59 am | News | Comments

This acquisition builds on Allergan's world-class position and leadership strategy in mental health. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading